MNOV Q2 2025 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena

MNOVMediciNova, Inc.

$69M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$134,599

Gross Profit

$18,25013.6% margin

Operating Income

-$4M-2679.9% margin

Net Income

-$3M-2437.7% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$204,897

Balance Sheet

Total Assets

$50M

Total Liabilities

$3M

Stockholders' Equity

$47M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$134,599	$0	—
Gross Profit	$18,250	$0	—
Operating Income	-$4M	-$3M	-18.4%
Net Income	-$3M	-$3M	-24.8%